BRTX-100

N/A

Report date: 2025/03/03 10:50:37

Base Information

Drug NameBRTX-100

Drug Alias NamebrtxDISC自体骨髓间充质干细胞疗法brtxDISC cell therapyAutologous bone marrow-derived mesenchymal stem cells therapyBRTX-100

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIntervertebral disc disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiorestorative Therapies Inc

China Registration ClassN/A

Develop Information

Active CompaniesBiorestorative Therapies Inc

Inactive CompaniesN/A

Active IndicationsIntervertebral disc disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A